Terminology
The terminology used in this unit to explain the dose response relationship is as follows:
LO glossary element icon
Glossary
Dose
The dose is the quantity of the compound received by the subject.
LO glossary element icon
Glossary
LD50
The LD (lethal dose)50 is the dose which kills 50% of the exposed population.
LO glossary element icon
Glossary
ID50
The ID (incapacitating dose)50 is the dose which incapacitates 50% of the exposed population.
LO glossary element icon
Glossary
Ct (Concentration time)
The Ct is a measure of exposure to a vapor or aerosol. The concentration in the air and the time of exposure govern the dose received, as dose rate of respiration. It is assumed that, when the product of concentration and time is constant, so is the biological effect over a limited range of concentration and time. For very short or long exposures the biological effect may vary. Concentration is expressed as milligram per cubic meter (mg/m3) and time as minutes, so that the concentration time (Ct) is expressed as milligram-minutes per cubic meter (mg-min/m3).
LO glossary element icon
Glossary
LCt50
The LCt (lethal concentration time)50 is the Ct which will kill 50% of the exposed population.
LO glossary element icon
Glossary
ICt50
The ICt (incapacitating concentration time)50 is the Ct which will incapacitate 50% of the exposed population.

Death would occur if sufficient quantities of any substance were taken into the body. For example, if a large group of people with similar characteristics ate half a pound of table salt, half of them would probably die. Through experiments, scientists try to establish the particular dosage of chemical (in mass per kilogram of body weight) that will result in the death of half the test animals: that is the Lethal Dose for 50% or LD50. They also try to establish the point at the other end of the curve at which there is no observable effect from the substance on the animal. This is called the NOAEL: No Observable Adverse Effect Level.

Once the LD50 for a substance has been established by repeated experiments with animals, it must be extrapolated to determine what the LD50 would be for humans. This means adjusting the results to apply to human body weight and similar characteristics. But a toxic substance often has different effects on different species, so tests on animals cannot predict the exact effect that the substance will have on a human population. As a result, scientists are usually quite conservative in their estimates, which mean that they assume that the smallest dose that causes an effect in animals will also cause an effect in humans. In addition, scientists study the effect of a substance on human populations wherever statistics are available.

A toxic substance will sometimes combine with another substance to create a new chemical. The potential for harm of this new chemical can be greater or lesser than that of its individual components.

Another uncertainty associated with the LD50 concept is that most LD50 data is gained from acute exposure (single dose) testing rather than by chronic exposure. Extrapolation from these studies is complicated by the fact that chemicals are sometimes distributed differently in the body when the exposure is chronic; for example, a different target organ may be attacked, or the material may be excreted more easily.

Given these uncertainties, it is understandable why there is often considerable debate about what constitutes a “safe” level of exposure. For most substances, agency experts extrapolate conservatively from the NOAEL to set exposure limits for humans. OSHA uses Permissible Exposure Limits (PELs), while the American Conference of Governmental Industrial Hygienist (ACGIH) uses Threshold Limit Values (TLVs), to define the workroom air concentration that is considered a safe upper limit of exposure. For carcinogens and mutagens, however, there is considered to be no such “safe” exposure limit for regulatory purposes. Every exposure carries some risk.